Total Payments
$495,880
2024 Payments
$57,922
Companies
60
Transactions
2,284
Medicare Patients
3,536
Medicare Billing
$595,994
Payment Breakdown by Category
Other$400,264 (80.7%)
Food & Beverage$49,481 (10.0%)
Consulting$26,679 (5.4%)
Travel$18,255 (3.7%)
Education$1,083 (0.2%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $387,154 | 213 | 78.1% |
| Food and Beverage | $49,481 | 1,891 | 10.0% |
| Consulting Fee | $26,679 | 16 | 5.4% |
| Travel and Lodging | $18,255 | 111 | 3.7% |
| Honoraria | $13,110 | 7 | 2.6% |
| Education | $1,083 | 44 | 0.2% |
| Gift | $118.80 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $282,299 | 522 | $0 (2024) |
| Lilly USA, LLC | $63,105 | 269 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $55,229 | 172 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $38,429 | 101 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31,487 | 143 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $4,019 | 109 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $2,803 | 41 | $0 (2024) |
| Mannkind Corporation | $2,112 | 95 | $0 (2024) |
| Dexcom, Inc. | $1,776 | 77 | $0 (2024) |
| Corcept Therapeutics | $1,456 | 67 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,922 | 337 | Lilly USA, LLC ($30,705) |
| 2023 | $73,807 | 322 | Lilly USA, LLC ($27,006) |
| 2022 | $60,753 | 324 | Novo Nordisk Inc ($55,382) |
| 2021 | $36,044 | 244 | Novo Nordisk Inc ($31,854) |
| 2020 | $34,913 | 184 | Novo Nordisk Inc ($23,781) |
| 2019 | $52,325 | 284 | Novo Nordisk Inc ($46,635) |
| 2018 | $81,984 | 295 | Novo Nordisk Inc ($55,050) |
| 2017 | $98,132 | 294 | Novo Nordisk Inc ($43,023) |
All Payment Transactions
2,284 individual payment records from CMS Open Payments — Page 1 of 92
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Automated insulin delivery system | ||||||
| 12/20/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $20.86 | General |
| 12/20/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Insulin Pump | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $162.00 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $35.62 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/10/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 12/10/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes Care | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/30/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $325.00 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 831 | 1,696 | $380,000 | $139,013 |
| 2022 | 10 | 955 | 2,440 | $425,105 | $180,010 |
| 2021 | 11 | 885 | 1,648 | $359,275 | $152,441 |
| 2020 | 8 | 865 | 1,627 | $352,029 | $124,529 |
Total Patients
3,536
Total Services
7,411
Medicare Billing
$595,994
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 388 | 699 | $192,225 | $68,360 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 351 | $70,000 | $22,579 | 32.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 70 | 298 | $29,800 | $15,263 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 160 | $31,200 | $10,854 | 34.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 50 | $17,685 | $6,987 | 39.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 58 | $17,440 | $6,013 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $13,680 | $5,072 | 37.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 29 | $4,785 | $2,738 | 57.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,185 | $1,146 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 420 | 725 | $166,375 | $71,293 | 42.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 134 | 957 | $95,700 | $50,678 | 53.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 372 | $74,300 | $21,942 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 168 | $32,090 | $11,628 | 36.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 60 | 66 | $19,790 | $7,397 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $16,560 | $7,243 | 43.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 34 | $11,900 | $5,597 | 47.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 18 | $3,025 | $1,563 | 51.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $2,890 | $1,336 | 46.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 27 | 33 | $2,475 | $1,334 | 53.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 436 | 787 | $173,140 | $83,876 | 48.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 93 | 448 | $89,600 | $26,831 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 95 | 100 | $35,000 | $16,758 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 142 | $26,980 | $10,441 | 38.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 65 | 65 | $19,500 | $9,018 | 46.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 20 | 22 | $3,630 | $1,959 | 54.0% |
About Dr. Terrence Swade, M.D
Dr. Terrence Swade, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Lombard, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699847202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terrence Swade, M.D has received a total of $495,880 in payments from pharmaceutical and medical device companies, with $57,922 received in 2024. These payments were reported across 2,284 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($387,154).
As a Medicare-enrolled provider, Swade has provided services to 3,536 Medicare beneficiaries, totaling 7,411 services with total Medicare billing of $595,994. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Lombard, IL
- Active Since 11/15/2006
- Last Updated 02/20/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1699847202
Products in Payments
- Ozempic (Drug) $95,966
- MOUNJARO (Drug) $54,309
- Tresiba (Drug) $53,062
- FARXIGA (Drug) $46,491
- GVOKE HYPOPEN (Drug) $37,730
- JARDIANCE (Drug) $34,974
- RYBELSUS (Drug) $32,481
- Rybelsus (Drug) $29,818
- Victoza (Drug) $22,069
- Xultophy 100/3.6 (Drug) $13,559
- BYDUREON (Drug) $8,179
- t:slim X2 Insulin Pump with Control-IQ (Device) $2,299
- AFREZZA (Drug) $2,112
- Korlym (Drug) $1,456
- Kerendia (Drug) $1,408
- Vascepa (Drug) $1,319
- Dexcom G6 Transmitter (Medical Supply) $1,072
- TRULICITY (Drug) $781.06
- TRADJENTA (Drug) $651.66
- SOLIQUA 100/33 (Biological) $580.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.